Saumik Biswas
CEO
Tenomix Inc.
10/10Traction
Tenomix has developed The Lymphonator, a bench-top robotic scanning device that assists pathology staff in the efficient identification and collection of lymph nodes from surgically removed colorectal cancer tissues. This technology addresses the labor-intensive and error-prone manual search process, ensuring accurate detection of smaller lymph nodes to enhance cancer staging and optimize patient care.
- Hardware
- Healthcare Technology
- Medical Devices
Updated 23 months ago
Funding
Raised to date
$190KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Manually searching for lymph nodes in surgically removed colorectal cancer tissues is labor-intensive, time-consuming, and prone to human error. Smaller lymph nodes can be missed during manual palpation, leading to inaccurate cancer staging.
Solution
Tenomix offers The Lymphonator, a bench-top robotic scanning device designed to improve the efficiency and accuracy of lymph node identification in colorectal cancer specimens. The Lymphonator automates the search process, guiding pathology staff to ensure reliable detection of lymph nodes, including smaller ones that may be missed through manual palpation. By enhancing the accuracy of lymph node retrieval, The Lymphonator improves cancer staging, which can lead to optimized patient care.
Target Audience
The primary target audience includes pathology staff in hospitals and cancer centers who process surgically removed colorectal cancer tissues.
Features
- Bench-top robotic system for automated lymph node detection
- Guides pathology staff in the identification process
- Improves detection of smaller lymph nodes compared to manual palpation
- Designed specifically for surgically removed colorectal cancer tissues